Treatment Offered at Sarasota Memorial Hospital Shows Promising Results Treating COVID-19

Business

SRQ DAILY FRESHLY SQUEEZED CONTENT EVERY MORNING THURSDAY APR 1, 2021

A monoclonal antibody cocktail developed by Regeneron cut the risk of hospitalization and death by 70 percent when given to high-risk Covid-19 patients in a large clinical trial, the drug maker announced last week. SMH was among 27 sites participating in the trial, which produced the most definitive evidence yet that the medicine can aid recovery early in the course of disease. “From August 2020 to January 2021, SMH did a lot of this groundbreaking research and many of our selfless, heroic patients participated as volunteers,” said Manuel Gordillo, MD, medical director of Infection Prevention & Control at SMH. “The results are very encouraging and a potential game changer.”

« View The Thursday Apr 1, 2021 SRQ Daily Edition
« Back To SRQ Daily Archive

Read More

Preferred SHORE Partners with Child Protection Center to Host Blood Drive

Preferred SHORE Partners with Child Protection Center to Host Blood Drive

Apr 14, 2021

Manatee Memorial Hospital Receives National Recognition from The Workplace Partnership for Life Program for Promoting Organ, Eye, and Tissue Donation

Manatee Memorial Hospital Receives National Recognition from The Workplace Partnership for Life Program for Promoting Organ, Eye, and Tissue Donation

Apr 5, 2021

Sarasota Arts Organizations Come Together For Unified Approach To Safety Measures

Sarasota Arts Organizations Come Together For Unified Approach To Safety Measures

Apr 2, 2021

First Hospitals in Manatee and Sarasota Counties to Offer HeartFlow FFRCT Analysis for Cardiac Patients

First Hospitals in Manatee and Sarasota Counties to Offer HeartFlow FFRCT Analysis for Cardiac Patients

Mar 23, 2021